Calidi Biotherapeutics Inc.

CLDI | AMEX

Price Alert Chart Builder DCF Calculator

$1.11

+$0.01 (+0.91%)

At close: Sep 21, 2026, 3:59 PM ET

$1.10

-$0.01 (-0.90%)

Pre-market: Sep 22, 2026, 8:43 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.91%

(1D)

Rating

Updated: Sep 7, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $512.14K

1D Range

1.11 1.16

52W Range

1.05 27.84

Valuation (TTM)

PE -0.02

PB 0.16

EV/EBITDA 0.14

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target $5.50

Cash Flow

FCF Yield -3476.9%

SBC Adj. FCF Yield -3743.9%

SBC Impact -7.7%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | -100.0%

Dil EPS 3Y | 5Y 118.5% | 40.8%

FCF 3Y | 5Y 19.6% | -18.2%

Returns

ROA -242.6%

ROE -372.9%

ROIC -347.1%

Financial Health

Net Cash

$2.73M

Current Ratio 1.68

Interest Coverage -114.43

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Calidi Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on immuno-oncology, dedicated to developing advanced immunotherapies for various cancers. The company's innovative approa...

Sector Healthcare

Industry Biotechnology

Employees 29

IPO Date Oct 31, 2021

Website calidibio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.